Axon Therapies is a private medtech company focused on bringing more treatment options to heart failure patients, particularly those with preserved ejection fraction. They have developed the SAVM procedure, a novel approach to modulating the body's sympathetic nervous system to restore balance in the circulatory system, aiming to enhance functional capacity and quality of life for heart failure patients. The company is dedicated to pioneering groundbreaking technology and has assembled a team of innovators passionate about improving the lives of heart failure patients globally. Through collaboration with clinical partners, Axon Therapies is on a path to revolutionizing heart failure treatment.